Article
Coronavirus Vaccine Updates: Novavax nears end of US trial, could submit to FDA in May
Rating:
0.0
Views:
75
Likes:
1
Library:
1
Novavax, a biotechnology company developing a two-dose COVID-19 vaccine, has released its product's efficacy.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value